Education
About Us
Working with TipRanks
Follow Us
Ilika PLC (GB:IKA)
LSE:IKA
IKA Stock Chart & Stats
37.50p
1.00p(4.76%)
At close: 4:00 PM EST
37.50p
1.00p(4.76%)
Day’s Range― - ―
52-Week Range26.50p - 51.00p
Previous CloseN/A
Volume109.22K
Average Volume (3M)289.65K
Market Cap
£49.73M
Enterprise Value42.74M
Total Cash (Recent Filing)£6.92M
Total Debt (Recent Filing)£562.20K
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Jul 09, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding180,832,170
10 Day Avg. Volume333,759
30 Day Avg. Volume289,646
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)2.38
Price to Sales (P/S)2413.15
P/FCF Ratio-11.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Commercialisation Progress: Stereax Production & DeliveriesMoving Stereax from lab to qualified manufacturing and initial customer deliveries materially reduces commercialization risk. Cirtec qualification and first cathode purchase order create an early revenue path, prove partner manufacturing capability and support scaled, repeatable supply chains over the coming 2-6 months.
Goliath Prototyping & Automated Pilot-line Scale-upValidated 10 Ah prototypes and an automated pilot line demonstrate manufacturability at higher energy densities. This reduces technical and scale-up risk, strengthens OEM engagement and underpins licensing discussions — a durable operational milestone that supports future royalty and manufacturing revenue streams.
IP Depth And Asset‑light Licensing Go‑to‑marketA 78‑patent portfolio combined with an asset‑light licensing model creates a sustainable competitive moat. Licensing, NRE and royalties can scale without heavy capex, enabling recurring revenue and partner-led deployment — a structurally attractive route to commercial scale and margin improvement over time.
Bears Say
Severe Revenue Decline And Persistent UnprofitabilityA near‑total revenue decline and multi‑level negative margins indicate deep operating leverage shortfalls. Persistent losses erode retained earnings, limit reinvestment capacity, and force reliance on external funding or grants, impairing the company's ability to execute commercial scale‑up without sustained capital support.
Negative Operating And Free Cash Flow; Cash Runway PressureDeclining cash and negative operating/free cash flow increase financing risk during a capital‑intensive scale phase. While grants and R&D tax credits help, the company must conserve cash or secure funding, which can slow commercialization, dilute shareholders or constrain production ramp timelines if not addressed.
Extended Timeline And Uncertainty To Monetise Goliath LicensingA multi‑year licensing timeline delays meaningful recurring revenue from Goliath and keeps material monetisation uncertain. Prolonged negotiations and pending external validation mean R&D and pilot costs persist, raising execution risk and lengthening the period before royalties or scale licensing materially bolster cash flow.
Ilika plc News
IKA FAQ
What was Ilika PLC’s price range in the past 12 months?
Ilika PLC lowest share price was 26.50p and its highest was 51.00p in the past 12 months.
What is Ilika PLC’s market cap?
Ilika PLC’s market cap is £49.73M.
When is Ilika PLC’s upcoming earnings report date?
Ilika PLC’s upcoming earnings report date is Jul 09, 2026 which is in 138 days.
How were Ilika PLC’s earnings last quarter?
Ilika PLC released its earnings results on Jan 22, 2026. The company reported -0.02p earnings per share for the quarter, missing the consensus estimate of N/A by -0.02p.
Is Ilika PLC overvalued?
According to Wall Street analysts Ilika PLC’s price is currently Overvalued.
Does Ilika PLC pay dividends?
Ilika PLC does not currently pay dividends.
What is Ilika PLC’s EPS estimate?
Ilika PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ilika PLC have?
Ilika PLC has 180,832,170 shares outstanding.
What happened to Ilika PLC’s price movement after its last earnings report?
Ilika PLC reported an EPS of -0.02p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.632%.
Which hedge fund is a major shareholder of Ilika PLC?
Currently, no hedge funds are holding shares in GB:IKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ilika plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
GB:IKA Sentiment 100%
Sector Average 67%
Sector Average 67%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
89.58%
12-Months-Change
Fundamentals
Return on Equity
-31.45%
Trailing 12-Months
Asset Growth
-14.80%
Trailing 12-Months
Company Description
Ilika PLC
Ilika plc engages in the design, development, and production of solid-state batteries under the Stereax name primarily in the United Kingdom, Asia, rest of Europe, and North America. It offers batteries for a range of applications in the industrial Internet of Things, medical, transportation, electric vehicles, and cordless consumer electronics/ smart cities. The company was founded in 2004 and is headquartered in Romsey, the United Kingdom.
Technical Analysis
Options Prices
Currently, No data available
---